JP2025090801A5 - - Google Patents
Info
- Publication number
- JP2025090801A5 JP2025090801A5 JP2025041934A JP2025041934A JP2025090801A5 JP 2025090801 A5 JP2025090801 A5 JP 2025090801A5 JP 2025041934 A JP2025041934 A JP 2025041934A JP 2025041934 A JP2025041934 A JP 2025041934A JP 2025090801 A5 JP2025090801 A5 JP 2025090801A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562102245P | 2015-01-12 | 2015-01-12 | |
| US62/102,245 | 2015-01-12 | ||
| JP2020213211A JP7410846B2 (ja) | 2015-01-12 | 2020-12-23 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2023015047A JP7719816B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023015047A Division JP7719816B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025090801A JP2025090801A (ja) | 2025-06-17 |
| JP2025090801A5 true JP2025090801A5 (https=) | 2025-11-06 |
Family
ID=56406560
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555445A Pending JP2018501322A (ja) | 2015-01-12 | 2016-01-12 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2020213210A Active JP7410845B2 (ja) | 2015-01-12 | 2020-12-23 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2020213211A Active JP7410846B2 (ja) | 2015-01-12 | 2020-12-23 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2023015026A Active JP7719815B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2023015047A Active JP7719816B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2025041934A Pending JP2025090801A (ja) | 2015-01-12 | 2025-03-14 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2025041931A Pending JP2025094038A (ja) | 2015-01-12 | 2025-03-14 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555445A Pending JP2018501322A (ja) | 2015-01-12 | 2016-01-12 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2020213210A Active JP7410845B2 (ja) | 2015-01-12 | 2020-12-23 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2020213211A Active JP7410846B2 (ja) | 2015-01-12 | 2020-12-23 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2023015026A Active JP7719815B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| JP2023015047A Active JP7719816B2 (ja) | 2015-01-12 | 2023-02-03 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025041931A Pending JP2025094038A (ja) | 2015-01-12 | 2025-03-14 | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
Country Status (7)
| Country | Link |
|---|---|
| US (7) | US20180318414A1 (https=) |
| EP (2) | EP3244923B1 (https=) |
| JP (7) | JP2018501322A (https=) |
| AU (2) | AU2021200638B2 (https=) |
| CA (1) | CA2973585A1 (https=) |
| ES (1) | ES3057334T3 (https=) |
| WO (1) | WO2016115097A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018501322A (ja) | 2015-01-12 | 2018-01-18 | チルドレンズ メディカル センター コーポレーション | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| US20190269775A1 (en) * | 2016-11-14 | 2019-09-05 | Dana-Farber Cancer Institute, Inc. | Compositions and methods of treating cancer |
| US20220175926A1 (en) * | 2019-03-29 | 2022-06-09 | The Brigham And Women's Hospital, Inc. | Targeted synergistic cancer immunotherapy |
| JP2022552200A (ja) * | 2019-10-07 | 2022-12-15 | ノースウエスト バイオセラピューティクス，インコーポレイティド | 樹状細胞およびＴ細胞の活性化を増強するためのならびにＴＨ－１免疫応答を誘導するためのｉｎ ｖｉｔｒｏの方法および組成物 |
| EP4061423A4 (en) * | 2019-11-18 | 2023-12-06 | Children's Medical Center Corporation | HYPERACTIVE DENDRITIC CELLS FOR PERMANENT ANTITUMOR EFFECT ON ADOPTIONAL CELL TRANSFER BASIS |
| CN114980919B (zh) * | 2019-11-18 | 2026-04-14 | 儿童医学中心公司 | 过度活化驻留树突状细胞的刺激物用于癌症免疫疗法 |
| CN114894910B (zh) * | 2022-03-18 | 2023-10-20 | 重庆医科大学附属第一医院 | 1-棕榈酰-2-花生四烯酰-sn-甘油-3-磷酸胆碱检测试剂的新用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5158939A (en) * | 1989-07-21 | 1992-10-27 | Wisconsin Alumni Research Foundation | Method of stimulating the immune systems of animals and compositions useful therefor |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| DE69428764T2 (de) | 1993-12-24 | 2002-06-20 | Merck Patent Gmbh | Immunokonjugate |
| AU762369B2 (en) * | 1998-11-03 | 2003-06-26 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | LPS with reduced toxicity from genetically modified gram negative bacteria |
| AU2003243806A1 (en) * | 2002-07-15 | 2004-02-02 | Bernd Binder | Lipid oxidation products for inhibiting inflammation |
| US20060257359A1 (en) | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
| US8961982B2 (en) * | 2005-12-16 | 2015-02-24 | The Regents Of The University Of California | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
| AU2007306936B2 (en) * | 2006-10-12 | 2014-02-06 | The University Of Queensland | Compositions and methods for modulating immune responses |
| KR101408445B1 (ko) | 2009-07-27 | 2014-06-17 | 가부시키가이샤 고베 세이코쇼 | 배선 구조 및 그 제조 방법 및 배선 구조를 구비한 표시 장치 |
| ES2769326T3 (es) | 2010-02-05 | 2020-06-25 | Univ Cornell | Métodos y composiciones para la inmunoterapia contra el cáncer usando células tumorales que expresan la proteína de fusión de flagelina y antígeno asociado al tumor |
| BR112012027745A2 (pt) | 2010-04-27 | 2017-01-10 | Univ Johns Hopkins | método e composição imunogênica para tratamento de neoplásia |
| WO2012177624A2 (en) | 2011-06-21 | 2012-12-27 | The Johns Hopkins University | Focused radiation for augmenting immune-based therapies against neoplasms |
| ES2758923T3 (es) * | 2011-12-12 | 2020-05-07 | Vascular Biogenics Ltd | Tratamiento de esteatohepatitis no alcohólica |
| WO2014164699A1 (en) * | 2013-03-11 | 2014-10-09 | The Regents Of The University Of California | Herpes virus vaccines and treatments |
| US10253294B2 (en) | 2013-12-18 | 2019-04-09 | Julius-Maximilians-Universität Würzburg | Galactose oxidase treatment of dendritic cells to improve their immunogenicity |
| JP2018501322A (ja) * | 2015-01-12 | 2018-01-18 | チルドレンズ メディカル センター コーポレーション | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| KR102873947B1 (ko) | 2015-05-07 | 2025-10-22 | 베이롤 칼리지 오브 메드신 | 수지상 세포 면역요법 |
| MA44252A (fr) | 2016-02-16 | 2018-12-26 | Harvard College | Vaccins contre des agents pathogènes et leurs procédés de production et d'utilisation |
| CA3028654A1 (en) | 2016-06-27 | 2018-01-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Therapeutic antitumor combination of a tlr4 ligand with other treatments |
| WO2018067302A2 (en) | 2016-09-19 | 2018-04-12 | North Western University | Therapeutic effects of cellular delivery of small molecules and macromolecules with liposomal spherical nucleic acids |
| JP7355394B2 (ja) | 2018-05-03 | 2023-10-03 | エル．イー．エー．エフ． ホールディングス グループ エルエルシー | カロテノイド組成物およびその使用 |
| JP2022552200A (ja) | 2019-10-07 | 2022-12-15 | ノースウエスト バイオセラピューティクス，インコーポレイティド | 樹状細胞およびＴ細胞の活性化を増強するためのならびにＴＨ－１免疫応答を誘導するためのｉｎ ｖｉｔｒｏの方法および組成物 |
| CN114980919B (zh) | 2019-11-18 | 2026-04-14 | 儿童医学中心公司 | 过度活化驻留树突状细胞的刺激物用于癌症免疫疗法 |
| EP4061423A4 (en) | 2019-11-18 | 2023-12-06 | Children's Medical Center Corporation | HYPERACTIVE DENDRITIC CELLS FOR PERMANENT ANTITUMOR EFFECT ON ADOPTIONAL CELL TRANSFER BASIS |
-
2016
- 2016-01-12 JP JP2017555445A patent/JP2018501322A/ja active Pending
- 2016-01-12 EP EP16737709.2A patent/EP3244923B1/en active Active
- 2016-01-12 WO PCT/US2016/012994 patent/WO2016115097A2/en not_active Ceased
- 2016-01-12 EP EP25205526.4A patent/EP4681782A3/en active Pending
- 2016-01-12 CA CA2973585A patent/CA2973585A1/en active Pending
- 2016-01-12 US US15/543,165 patent/US20180318414A1/en not_active Abandoned
- 2016-01-12 ES ES16737709T patent/ES3057334T3/es active Active
-
2020
- 2020-09-11 US US17/018,038 patent/US11400153B2/en active Active
- 2020-09-11 US US17/018,045 patent/US11351250B2/en active Active
- 2020-12-23 JP JP2020213210A patent/JP7410845B2/ja active Active
- 2020-12-23 JP JP2020213211A patent/JP7410846B2/ja active Active
-
2021
- 2021-02-01 AU AU2021200638A patent/AU2021200638B2/en active Active
-
2022
- 2022-04-26 US US17/730,030 patent/US12070499B2/en active Active
- 2022-05-09 US US17/739,953 patent/US12053522B2/en active Active
-
2023
- 2023-02-03 JP JP2023015026A patent/JP7719815B2/ja active Active
- 2023-02-03 JP JP2023015047A patent/JP7719816B2/ja active Active
-
2024
- 2024-06-18 US US18/746,749 patent/US20240415957A1/en active Pending
- 2024-07-17 US US18/774,985 patent/US20250025552A1/en active Pending
- 2024-09-06 AU AU2024219454A patent/AU2024219454A1/en active Pending
-
2025
- 2025-03-14 JP JP2025041934A patent/JP2025090801A/ja active Pending
- 2025-03-14 JP JP2025041931A patent/JP2025094038A/ja active Pending